Soft Tissue Sarcoma: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for soft tissue sarcomas. To learn more about a study, choose from the list below.

Showing 20 trials
Title Investigator
A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas
[Protocol 10-049] 		Gounder, Mrinal, MD
A Phase I Study Assessing the Effects of Food and Formulation on the Processing of KPT-330 in Patients with Sarcoma
[Protocol 13-145] 		Gounder, Mrinal, MD
A Phase I Study of Dasatinib and Ipilimumab for Patients with Advanced GIST or Other Sarcomas
[Protocol 12-083] 		Carvajal, Richard, MD
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 11-009] 		Basu, Ellen, MD, PhD
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 12-116] 		Roberts, Stephen, MD
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156] 		Tap, William, MD
A Phase I Study of SAR405838 in Patients with Advanced Cancer
[Protocol 13-093] 		Schwartz, Gary, MD
A Phase I/II Study of Sunitinib in Young Patients with Advanced Gastrointestinal Stromal Tumors
[Protocol 12-226] 		Magnan, Heather, MD
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
[Protocol 11-183] 		Trippett, Tanya, MD
A Phase II Study of Irinotecan and Temozolomide in Combination with Existing High-Dose Chemotherapy for Patients Newly Diagnosed with Ewing Sarcoma
[Protocol 13-068] 		Magnan, Heather, MD
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194] 		Dickson, Mark, MD
A Phase II Study of MLN8237 in Patients with Recurrent or Persistent Uterine Leiomyosarcoma
[Protocol 12-164] 		Hyman, David, MD
A Phase II Study of PD0332991 in Patients with Advanced or Metastatic Liposarcoma
[Protocol 10-094] 		Dickson, Mark, MD
A Phase II Study of Sunitinib or Cediranib for Inoperable Metastatic Alveolar Soft Part Sarcoma
[Protocol 12-095] 		Keohan, Mary, MD
A Phase II Study of Trebananib (AMG 386) for the Treatment of Inoperable Advanced Angiosarcoma
[Protocol 12-128] 		D'Angelo, Sandra, MD
A Phase III Study of Doxorubicin Alone or in Combination with TH-302 in Patients with Locally Advanced Inoperable or Metastatic Soft-Tissue Sarcoma
[Protocol 11-203] 		Tap, William, MD
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177] 		Hensley, Martee, MD
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007] 		Hensley, Martee, MD
A Phase III Study of Trabectedin or Dacarbazine for Previously Treated Advanced Liposarcoma or Leiomyosarcoma
[Protocol 11-143] 		Hensley, Martee, MD
A Pilot Trial of Irinotecan, Temozolomide, and Bevacizumab plus High-Dose Chemotherapy for Newly Diagnosed Patients with Desmoplastic Small Round Cell Tumor
[Protocol 10-091] 		Magnan, Heather, MD
On Our Blog
Recommended Links

Making an Appointment

Contact our Physician Referral Service to schedule a consultation with a Memorial Sloan-Kettering physician in Manhattan or at one of our suburban regional cancer centers.

Learn more »

Other Useful Information